Concomitant Lethal Mutagenesis of Human Immunodeficiency Virus Type 1
- 1 June 2012
- journal article
- Published by Elsevier in Journal of Molecular Biology
- Vol. 419 (3-4) , 158-170
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (R01 GM56615)
- National Institutes of Health (T32DA007097, T32DE007288)
This publication has 65 references indexed in Scilit:
- Human APOBEC3G-Mediated Editing Can Promote HIV-1 Sequence Diversification and Accelerate Adaptation to Selective PressureJournal of Virology, 2010
- APOBEC3G Contributes to HIV-1 Variation through Sublethal MutagenesisJournal of Virology, 2010
- Interactions of host APOBEC3 restriction factors with HIV-1 in vivo: implications for therapeuticsExpert Reviews in Molecular Medicine, 2010
- Effect of Ribavirin on the Mutation Rate and Spectrum of Hepatitis C Virus In VivoJournal of Virology, 2009
- Dissecting APOBEC3G Substrate Specificity by Nucleoside Analog InterferenceJournal of Biological Chemistry, 2009
- Cytidine deamination induced HIV-1 drug resistanceProceedings of the National Academy of Sciences, 2008
- Population Level Analysis of Human Immunodeficiency Virus Type 1 Hypermutation and Its Relationship with APOBEC3G and vif Genetic VariationJournal of Virology, 2006
- Antiviral Potency of APOBEC Proteins Does Not Correlate with Cytidine DeaminationJournal of Virology, 2006
- Cytidine Deamination of Retroviral DNA by Diverse APOBEC ProteinsCurrent Biology, 2004
- Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcriptsNature, 2003